The medical affairs function has evolved dramatically to become a strategically essential asset for the life sciences industry, and the roles and responsibilities within the organization is experiencing tremendous growth and heightened visibility to executive leaders. The roles and responsibilities within the organization is experiencing tremendous growth and heightened visibility to executive leaders. Most recently, there have been increased demands for scientific evidence from the medical community due to the shift in research pipelines from chronic to rare disease therapies. This demand for evidence, coupled with limitations set by physician offices on commercial visitations, has been answered by an increased reliance on the medical affairs function.
Because of the increase in engagement from members of the healthcare community, the medical affairs function has also been subjected to an increased amount of regulatory scrutiny. This shift has caused a necessary progression of the medical affairs function from merely one of many important functions to a critically strategic, efficient and compliant arm of the organization. Nonetheless, this is a task that is easier said than done.
Listen to Baker Tilly’s and Accreditation Council for Medical Affairs’ (ACMA) on-demand webinar for an informative discussion regarding the changes taking place within medical affairs and how organizations can effectively address them through enhancement initiatives, accreditation measures and training programs. Our team of Value Architects™ and trusted specialists discuss: